Compare stocks

Aevis Victoria SA operates in the healthcare and hospitality sectors, primarily focused on the management of private clinics and luxury hotels. The company owns and manages a network of Swiss private clinics through its subsidiary, Swiss Medical Network, providing a range of medical services. In the hospitality segment, Aevis Victoria has investments in several luxury hotels under its subsidiary, Victoria-Jungfrau Collection, offering upscale accommodation and services in Switzerland. Headquartered in Fribourg, Switzerland, the company benefits from its strategic positioning in high-demand markets, leveraging its expertise to integrate healthcare services with hospitality. Its diverse portfolio across healthcare and luxury accommodations forms the basis of its business model.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.